Metabolic decompensation may occur in patients with disorders of intermediary metabolism during intercurrent illness. To prevent complications it is normal practice to change the diet to an 'emergency regimen'. The mainstay of this is a high carbohydrate intake, using soluble glucose polymer, given as frequent drinks by day and during the night. Additional therapy is given for some disorders. Practical details of the treatment are outlined. (Arch Dis Child 1992;67:1387-91) Diet is the mainstay of treatment for many inborn errors of intermediary metabolism.' Patients are stabilised on a diet appropriate for their disorder that will provide them with sufficient nutrients and energy to grow and develop normally. However metabolic stress such as intercurrent infections may precipitate decompensation and cause complications. To prevent these it is common for the diet to be changed to an 'emergency regimen'. The purpose of this paper is to outline the principles and practice of these regimens. Principles During illness and fasting various metabolic adaptations occur.2
There is constant turnover of tissue protein and overall, the rate of protein synthesis exceeds that of breakdown so there is net gain and hence growth.3 However, during illness the rate of protein breakdown normally exceeds that of synthesis with net production of amino acids and an increase in their irreversible catabolism. The nitrogen moiety of amino acids is converted to ammonia and then to urea. The carbon skeleton of amino acids is progressively catabolised to form fuels for energy production including acetyl CoA, pyruvate, and intermediates of the Krebs cycle.
(B) SUBSTRATES FOR ENERGY PRODUCTION
Glucose is a major fuel for energy metabolism but glycogen reserves for glucose production during fasting are relatively limited in children.
To maintain a supply of substrate for energy production and protect glucose supply to the brain it is necessary to mobilise alternative fuels, including free fatty acids, ketones, and gluconeogenic precursors.
On fasting, as glucose concentrations slowly fall, there is a decrease in the insulin:glucagon ratio with mobilisation of fatty acids from adipose tissue stores. Free fatty acids can be utilised by many tissues, such as the heart and skeletal muscle, but they cannot enter the brain. In the liver, free fatty acids are partially oxidised to ketones which are water soluble and can enter the central nervous system. Alanine and other amino acids from muscle catabolism and glycerol from lipolysis are substrates for gluconeogenesis. regimen of drinks every two hours should be started. There is some flexibility in the frequency of the drinks particularly in the older children and during recovery. During illness most children will automatically stop eating the normal diet, and once the child starts to improve the usual diet is gradually reintroduced. (3) If the child is refusing to take the drinks, is vomiting frequently, or becoming encephalopathic then they should be admitted to hospital for assessment. The parents need to be aware of and recognise clinical signs of deterioration. Of particular importance is the ability to recognise encephalopathy with the child becoming less responsive, often with a glazed look.
Parents may face difficulties if the child does not take all the recommended volumes of feed. The quantities necessary vary both with the underlying inborn error and the intercurrent illness. It is particularly important that patients with maple syrup urine disease and methylmalonic acidaemia should have close to the recommended volumes (see below). By contrast those with glycogen storage disease may be controlled satisfactorily with smaller volumes. Patients with gastroenteritis will in general need more fluid than those with upper respiratory tract infections.
It should be emphasised that the basic emergency regimen must not be continued for long periods of time because it does not provide adequate nutrition and will cause nutritional deficiencies. Early clinical signs of such deficiencies include skin rashes (particularly at the site of adhesive tape for nasogastric tubes). Most patients can be gradually returned to their usual diet within a few days.
When the diet is being reintroduced additional high carbohydrate drinks are given until the normal diet is re-established. In infants, additional glucose polymer is added to the formula feed. For In addition to the basic emergency regimen the usual medication should continue to be given. Both sodium benzoate and phenylbutyrate are given in a dose of 250 mg/kg/day but can be temporarily increased to 500 mg/kg/day during illness. Another consequence of these disorders is that arginine becomes an essential amino acid (except in arginase deficiency). During illness the normal arginine supplements, 100 mg/kg/ day, should be given. In citrullinaemia and argininosuccinic aciduria, arginine should be given in larger doses of up to 700 mg/kg/day to replenish ornithine that is not reformed as a result of the metabolic block. All the medication should be given in frequent small doses. If the child cannot tolerate oral fluids or medicines sodium benzoate, sodium phenylacetate, and arginine should be given intravenously.
Patients should be monitored with regular measurement of plasma ammonia and quantitative plasma amino acids. Protein can be reintroduced once the ammonia is less than 80 ,umol/l.
Occasionally it can be difficult to reintroduce protein without inducing hyperammonaemia and in these cases an essential amino acid supplement (for example Dialamine, Scientific Hospital Supplies, see appendix), can be given. This will promote both protein synthesis and the reutilisation of nitrogen to form nonessential amino acids thereby reducing ammonia accumulation.
TYROSINAEMIA TYPE I (FUMARYLACETOACETASE DEFICIENCY)
Tyrosinaemia type I is caused by a deficiency of fumarylacetoacetase, the last enzyme of the catabolic pathway of tyrosine, with resultant accumulation of succinylacetone and related metabolites. Patients are usually treated with a diet restricted in tyrosine and phenylalanine. Although it is not common to use an emergency regimen in this disorder, decompensation of liver function and deterioration of neurological function can follow intercurrent infection. It is probably beneficial that an emergency regimen is given to reduce these problems. The patients may also need appropriate treatment for liver failure.
ORGANIC ACIDAEMIAS (a) Propionic and methylmalonic acidaemia Propionic and methylmalonic acidaemia are caused by inherited enzyme defects in the pathways of propionate catabolism. Propionate is formed from several sources including the amino acids isoleucine, valine, methionine, and threonine, by anaerobic bacterial fermentation in the gut and catabolism of odd chain fatty acids. Although amino acids are widely regarded as the major source of propionate, only about 50% of propionate is derived from breakdown of amino acids.6 About 20% is derived from the gut6 and the rest (30%) probably from the catabolism of odd chain fatty acids.7 The toxic metabolites and the mechanisms responsible for all the clinical problems are not well understood but the aim of treatment is to reduce the accumulation of propionate by diminishing production and increasing disposal.
In addition to the standard emergency regimen to reduce protein breakdown and amino acid catabolism, propionate production from the gut is reduced by giving metronidazole (or an alternative antibiotic). The removal of propionyl groups is enhanced by giving L-carnitine. This forms propionyl carnitine which is excreted in the urine. Carnitine is given either orally or intravenously in a dose of 100 mg/kg/day. Higher doses have been used although their value and complications have not been assessed critically. In methylmalonic acidaemia there is usually massive excretion of methylmalonate in the urine with obligatory simultaneous losses of sodium and potassium. These patients also have a concentrating and acidification defect in the kidney8 so it is essential to give sufficient fluid with supplements of sodium bicarbonate (2-3 mmol/kg) to replace sodium loss and reduce the acidosis. Patients may also need potassium supplements particularly during the recovery phase.
It may be helpful to monitor the patient's condition by measuring urine ketones but in our experience the parents' clinical judgment is as useful for most children.
It is important to reintroduce protein early (within two to three days) to prevent protein deficiency and additional problems such as rashes and vomiting.
(b) Isovaleric acidaemia Isovaleric acidaemia is due to a deficiency of isovaleryl-CoA dehydrogenase, the third step in the pathway of leucine degradation. Isovaleric acid accumulates and its excretion in the urine can be increased by giving L-carnitine (100 mg/ kg/day) and glycine (250 mg/kg/day). These are conjugated to form isovalerylcarnitine and isovalerylglycine respectively, both being rapidly excreted in the urine. This treatment can be given orally or intravenously.
(c) Other organic acidaemias (for example, 3-methyicrotonylglycinuria, glutaric aciduria type I)
In addition to the standard emergency regimen, L-carnitine is widely used to increase the removal of acyl groups, although controlled studies of its efficacy are lacking.
DISORDERS OF FATTY ACID OXIDATION
Inborn errors at several steps in the pathway of fatty acid oxidation are now well described, the most common is medium chain acyl CoA dehydrogenase deficiency. To prevent illness in these patients the standard emergency regimen is used. It is important to stress early use of the emergency regimen to inhibit mobilisation of fatty acids, particularly in long chain disorders because decompensation may be rapid. Additional treatment with L-carnitine is widely used but is somewhat controversial; there is little detailed critical work. Carnitine is essential in primary systemic carnitine deficiency and may be helpful in reversing decompensation in disorders of medium chain fatty acids. In theory carnitine in long chain fatty acid oxidation disorders might be harmful, by promoting the uptake of long chain fatty acids into mitochondria. Its use requires more evaluation.
Blood glucose is often used to monitor patients with these disorders, but this may give a false sense of security as patients may develop marked encephalopathy before blood glucose concentrations fall: treatment must be started before this.
Conclusions
The use of a well planned emergency regimen will not only help prevent episodes of metabolic decompensation, but Only the SHS products have been approved by the Advisory Committee Borderline Substances and can be prescribed on an FPIO. *1 kcal=4-18 kJ.
